281 related articles for article (PubMed ID: 11669332)
1. Low-energy electron emitters for targeted radiotherapy of small tumours.
Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
3. Model of metastatic growth valuable for radionuclide therapy.
Bernhardt P; Ahlman H; Forssell-Aronsson E
Med Phys; 2003 Dec; 30(12):3227-32. PubMed ID: 14713089
[TBL] [Abstract][Full Text] [Related]
4. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
[TBL] [Abstract][Full Text] [Related]
5. The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y.
Wheldon TE; O'Donoghue JA; Barrett A; Michalowski AS
Radiother Oncol; 1991 Jun; 21(2):91-9. PubMed ID: 1866470
[TBL] [Abstract][Full Text] [Related]
6. The radiobiology of targeted radiotherapy.
Wheldon TE; O'Donoghue JA
Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
[TBL] [Abstract][Full Text] [Related]
7. 119Sb--a potent Auger emitter for targeted radionuclide therapy.
Thisgaard H; Jensen M
Med Phys; 2008 Sep; 35(9):3839-46. PubMed ID: 18841834
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6.
Humm JL; Howell RW; Rao DV
Med Phys; 1994 Dec; 21(12):1901-15. PubMed ID: 7700197
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo Evaluation of Auger Electron-Emitting Theranostic Radionuclides.
Falzone N; Fernández-Varea JM; Flux G; Vallis KA
J Nucl Med; 2015 Sep; 56(9):1441-6. PubMed ID: 26205298
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
Karagiannis TC
Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
[TBL] [Abstract][Full Text] [Related]
13. Absorbed fractions in ellipsoidal volumes for beta(-) radionuclides employed in internal radiotherapy.
Amato E; Lizio D; Baldari S
Phys Med Biol; 2009 Jul; 54(13):4171-80. PubMed ID: 19521004
[TBL] [Abstract][Full Text] [Related]
14. Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations.
Pacilio M; Lanconelli N; Lo MS; Betti M; Montani L; Torres AL; Coca PM
Med Phys; 2009 May; 36(5):1543-52. PubMed ID: 19544770
[TBL] [Abstract][Full Text] [Related]
15. Absorbed fractions for electrons and beta particles in spheres of various sizes.
Siegel JA; Stabin MG
J Nucl Med; 1994 Jan; 35(1):152-6. PubMed ID: 8271037
[TBL] [Abstract][Full Text] [Related]
16. Absorbed dose distribution of the auger emitters 67GA and 125I and the beta-emitters 67CU, 90Y, 131I, and 186RE as a function of tumor size, uptake, and intracellular distribution.
van Dieren EB; Plaizier MA; van Lingen A; Roos JC; Barendsen GW; Teule GJ
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):197-204. PubMed ID: 8823276
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
18. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V
Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of high-energy brachytherapy source electronic disequilibrium and dose from emitted electrons.
Ballester F; Granero D; Pérez-Calatayud J; Melhus CS; Rivard MJ
Med Phys; 2009 Sep; 36(9):4250-6. PubMed ID: 19810499
[TBL] [Abstract][Full Text] [Related]
20. Cross-fire doses from beta-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristics.
Enger SA; Hartman T; Carlsson J; Lundqvist H
Phys Med Biol; 2008 Apr; 53(7):1909-20. PubMed ID: 18364546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]